Top Markets
#1 Useless Coin Useless Coin +40.04%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.79%
#3 StonkBroker StonkBroker +36.44%
#4 0G 0G +35.41%
#5 SAFEcoin SAFEcoin +28.81%
#6 Arbitrum Arbitrum +19.69%
#7 Zora Zora +19.48%
#8 Dogs Dogs +18.55%
#9 Full Moon Full Moon +18.06%
#10 Notcoin Notcoin +18.00%
Coin of the day
Useless Coin Useless Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Classifica tra le azioni #13779
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Prezzo delle azioni
$12.63
Capitalizzazione di mercato
$458.19M
Variazione (1 giorno)
-3.26%
Variazione (1 anno)
-
Paese
US
Scambia Evommune, Inc. (EVMN)

Categoria

Healthcare
Storico del prezzo dell'azione per Evommune, Inc. (EVMN)
Prezzo di chiusura più alto: $13.94 il 2026-08-01

Prezzo di chiusura più basso: $19.25 il 2025-11-01
Storico del prezzo dell'azione di Evommune, Inc. dal 2025 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 9.44%
2025 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.87%
CH